Research member Dr. Bertrand Routy, postdoctoral student Meriem Messaoudene and their team have published a study in the journal Cancer Discovery showing the anti-cancer benefits of the Brazilian camu-camu berry. Castalagin, a molecule from the Amazonian fruit, increases the effectiveness of immunotherapy by altering the microbiome.
The results of this study will allow clinical trials to begin. Castalagin will be used as an adjunct to drugs in certain cancer patients.
Gerardo Ferbeyre receives $2.4M Grant from the Terry Fox Research Institute
24 August 2023
Gerardo Ferbeyre, research member of the Montreal Cancer Institute and his team, will receive, as well as four other scientific […]
Manuela Santos’ team investigates the role of the gut microbiota
22 June 2021
The team of Dr. Manuela Santos, head of the Nutrition and Microbiome Laboratory at the CRCHUM and a member researcher […]